Allan Jonathan

General Counsel &Corp Sec | General Counsel &Corp Sec

1 company

Average

Trades Analyzed

12M Win Rate

25.0%

Avg 3M Return

-19.1%

Avg 12M Return

-45.9%

Allan Jonathan is a General Counsel &Corp Sec at Stoke Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 22 sells.

Estimated insider holdings value: $477K based on current market prices.

Holdings by Company

STOKDec 8, 2025

Current Shares14.5K

Value$477.2K

Net Activity-111,464

Bought: 0Sold: 111.5K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 8, 2025	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sell	3,978	$32.28	$128,411.36	-13.1%	+16.0%	-
Dec 5, 2025	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sale+OE	9,803	$31.25	$306,322.15	-8.4%	+12.2%	-
Dec 3, 2025	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sale+OE	4,576	$30.22	$138,268.18	-5.1%	+9.1%	-
Oct 3, 2025	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sale+OE	10,000	$25.07	$250,650.00	-45.8%	+20.9%	-
Sep 3, 2025	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sale+OE	22,117	$20.11	$444,808.64	-29.1%	+50.8%	-
Aug 18, 2025	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sell	1,683	$18.24	$30,694.55	-6.6%	+45.6%	-
Aug 13, 2025	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sell	13,712	$15.00	$205,680.00	-41.1%	+48.5%	-
Mar 19, 2025	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sell	4,211	$8.49	$35,731.37	-6.1%	+41.2%	+301.8%
Dec 9, 2024	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sell	13,666	$13.61	$185,978.06	-23.5%	-42.2%	+121.4%
Dec 6, 2024	STOK Stoke Therapeutics, Inc.	General Counsel &Corp Sec	Sell	9,696	$12.78	$123,890.64	-21.6%	-38.6%	+132.6%